Literature DB >> 33555377

Differences in surgical outcome between petroclival meningioma and anterior petrous meningioma.

In-Ho Jung1, Jihwan Yoo1, Hun Ho Park1, Chang-Ki Hong2,3.   

Abstract

BACKGROUND: Petroclival meningiomas (PC MNGs) and anterior petrous meningiomas (AP MNGs) have similar locations. However, these are different tumors clearly divided by the trigeminal nerve. There has never been a study on the comparison of the surgical outcomes of these two meningiomas. In this study, we compared and analyzed the surgical outcome of PC MNGs and AP MNGs.
METHODS: The charts of 85 patients diagnosed with PC MNGs of AP MNGs who underwent surgical treatment were retrospectively reviewed. And we analyzed the characteristics of 49 PC MNGs (57.6%) and compared them with those of 36 AP MNGs.
RESULTS: Preoperative brainstem edema was observed in 11 patients (22.4%) of the PC MNG group and 1 patient (2.8%) of the AP MNG group (p = 0.024). Total tumor removal was achieved in 21 patients (58.3%) of the AP MNG group, but only 17 patients (34.7%) of the PC MNG group were able to completely (p = 0.047). In addition, sixth cranial nerve palsy occurred in 17 patients (34.7%) of the PC MNG group and 4 patients (11.1%) of the AP MNG group (p = 0.025).
CONCLUSIONS: In this study, we found that PC MNGs has a worse surgical outcome than AP MNGs, because PC MNGs were difficult to completely remove and were more likely to damage abducens nerve.

Entities:  

Keywords:  Petroclival meningioma; Petrosal approach; Petrous meningioma; Retrosigmoid intradural suprameatal approach; Skull base surgery

Mesh:

Year:  2021        PMID: 33555377     DOI: 10.1007/s00701-021-04753-y

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  25 in total

1.  Meningiomas of the posterior fossa.

Authors:  F CASTELLANO; G RUGGIERO
Journal:  Acta Radiol Suppl       Date:  1953

2.  Petroclival meningiomas: study on outcomes, complications and recurrence rates.

Authors:  Anil Nanda; Vijayakumar Javalkar; Anirban Deep Banerjee
Journal:  J Neurosurg       Date:  2010-12-24       Impact factor: 5.115

3.  The incidence of primary intracranial neoplasms in Rochester, Minnesota, 1935-1977.

Authors:  L T Kurland; B S Schoenberg; J F Annegers; H Okazaki; C A Molgaard
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

4.  Surgical management of petroclival meningiomas: factors determining the choice of approach.

Authors:  Kadir Erkmen; Svetlana Pravdenkova; Ossama Al-Mefty
Journal:  Neurosurg Focus       Date:  2005-08-15       Impact factor: 4.047

5.  Meningiomas of the posterior fossa.

Authors:  R Martínez; J Vaquero; E Areitio; G Bravo
Journal:  Surg Neurol       Date:  1983-03

6.  Four subtypes of petroclival meningiomas: differences in symptoms and operative findings using the anterior transpetrosal approach.

Authors:  S Ichimura; T Kawase; S Onozuka; K Yoshida; T Ohira
Journal:  Acta Neurochir (Wien)       Date:  2008-06-12       Impact factor: 2.216

7.  Microsurgical removal of petroclival meningiomas: a report of 33 patients.

Authors:  A P Bricolo; S Turazzi; A Talacchi; L Cristofori
Journal:  Neurosurgery       Date:  1992-11       Impact factor: 4.654

8.  Experience with 36 surgical cases of petroclival meningiomas.

Authors:  M Samii; M Tatagiba
Journal:  Acta Neurochir (Wien)       Date:  1992       Impact factor: 2.216

9.  Epidemiology of brain tumors: the national survey of intracranial neoplasms.

Authors:  A E Walker; M Robins; F D Weinfeld
Journal:  Neurology       Date:  1985-02       Impact factor: 9.910

10.  Petroclival meningiomas: surgical experience in 109 cases.

Authors:  W T Couldwell; T Fukushima; S L Giannotta; M H Weiss
Journal:  J Neurosurg       Date:  1996-01       Impact factor: 5.115

View more
  1 in total

Review 1.  Midline Skull Base Meningiomas: Transcranial and Endonasal Perspectives.

Authors:  Ciro Mastantuoni; Luigi Maria Cavallo; Felice Esposito; Elena d'Avella; Oreste de Divitiis; Teresa Somma; Andrea Bocchino; Gianluca Lorenzo Fabozzi; Paolo Cappabianca; Domenico Solari
Journal:  Cancers (Basel)       Date:  2022-06-10       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.